Interpreting SARS-CoV-2 seroprevalence, deaths, and fatality rate — Making a case for standardized reporting to improve communication

Ioannidis, 2020, Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters, Environ. Res., 188, 10.1016/j.envres.2020.109890 Roser, 2020 Ioannidis, 2020, Forecasting for COVID-19 has failed, Int. J. Forecast. Xue, 2020, A data-driven network model for the emerging COVID-19 epidemics in Wuhan, Toronto and Italy, Math. Biosci., 326, 10.1016/j.mbs.2020.108391 Li, 2020, Modeling the impact of mass influenza vaccination and public health interventions on COVID-19 epidemics with limited detection capability, Math. Biosci. Acuña-Zegarra, 2020, Modeling behavioral change and COVID-19 containment in Mexico: A trade-off between lockdown and compliance, Math. Biosci., 325, 10.1016/j.mbs.2020.108370 Feng, 2020, On the benefits of flattening the curve: A perspective, Math. Biosci., 10.1016/j.mbs.2020.108389 F. Neil, 2020, Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand, Imp. Coll. COVID-19 Response Team Pollán, 2020, Prevalence of SARS-CoV-2 in Spain (ENE-COVID): A nationwide, population-based seroepidemiological study, Lancet, 396, 535, 10.1016/S0140-6736(20)31483-5 Ioannidis, 2021, The infection fatality rate of COVID-19 inferred from seroprevalence data, Bull World Health Organ, 99, 10.2471/BLT.20.265892 Meyerowitz-Katz, 2020, A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates, Int. J. Infect. Dis., 101, 138, 10.1016/j.ijid.2020.09.1464 Bendavid, 2020, COVID-19 antibody seroprevalence in Santa Clara County, California, MedRxiv Streeck, 2020, Infection fatality rate of SARS-CoV-2 infection in a german community with a super-spreading event, MedRxiv Silveira, 2020, Population-based surveys of antibodies against SARS-CoV-2 in southern Brazil, Nature Med., 26, 1196, 10.1038/s41591-020-0992-3 Reifer, 2020, SARS-CoV-2 IgG Antibody responses in New York City, Diagn. Microbiol. Infect. Dis., 98, 10.1016/j.diagmicrobio.2020.115128 Doi, 2020, Seroprevalence of novel coronavirus disease (COVID-19) in Kobe, Japan, MedRxiv Feehan, 2020, Point prevalence of SARS-CoV-2 and infection fatality rate in Orleans and Jefferson Parish, Louisiana, May 9–15, 2020, MedRxiv Erikstrup, 2020, Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors, Clin. Infect. Dis. Slot, 2020, Herd immunity is not a realistic exit strategy during a COVID-19 outbreak, Res. Sq. Thompson, 2020, Detection of neutralising antibodies to SARS Coronavirus 2 to determine population exposure in Scottish blood donors between March and May 2020, MedRxiv Ng, 2020, SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood, Nature Commun., 11, 4698, 10.1038/s41467-020-18468-8 Emmenegger, 2020, Early peak and rapid decline of SARS-CoV-2 seroprevalence in a Swiss metropolitan region, MedRxiv Fiore, 2020, Far away from herd immunity to SARS-CoV-2: results from a survey in healthy blood donors in south eastern Italy, MedRxiv Amorim Filho, 2020, Grupo hemorio de pesquisa em Covid-19, seroprevalence of anti-SARS-CoV-2 among blood donors in rio de janeiro, Brazil, Rev. Saude Publica, 54, 69, 10.11606/s1518-8787.2020054002643 Fontanet, 2020, Cluster of COVID-19 in northern France: A retrospective closed cohort study, MedRxiv Perez-Saez, 2020, Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland, Lancet Infect. Dis. Shakiba, 2021, Seroprevalence of COVID-19 virus infection in Guilan province, Iran, Emerg. Infect. Dis. Tess, 2020, SARS-CoV-2 seroprevalence in the municipality of Sao Paulo, Brazil, ten weeks after the first reported case, MedRxiv 2020 Hauser, 2020, Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in hubei, China, and six regions in Europe, PLOS Med., 17, 10.1371/journal.pmed.1003189 Guilmoto, 2020, COVID-19 death rates by age and sex and the resulting mortality vulnerability of countries and regions in the world, MedRxiv Comas-Herrera, 2020 Kelly, 2010, Length of stay for older adults residing in nursing homes at the end of life, J. Am. Geriatr. Soc., 58, 1701, 10.1111/j.1532-5415.2010.03005.x Rosenberg, 2020, Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York, Ann. Epidemiol., 48, 10.1016/j.annepidem.2020.06.004 Havers, 2020, Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States, March 23–May 12, JAMA Intern. Med., 180, 1576, 10.1001/jamainternmed.2020.4130 U.S. Bureau of Labor Statistics, 2020 2020 APM Research Lab Staff, 2020 Centers for Disease Control and Prevention, Using Antibody Tests, 2020 Lauer, 2020, The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application, Ann. Intern. Med, 172, 577, 10.7326/M20-0504 Bar-On, 2020, SARS-CoV-2 (COVID-19) by the numbers, eLife, 9, 10.7554/eLife.57309 Wilson, 2020, Case-fatality risk estimates for COVID-19 calculated by using a lag time for fatality, Emerg. Infect. Diseases, 26, 1339, 10.3201/eid2606.200320 Centers for Disease Control and Prevention, 2020 Adams, 2020, Antibody testing for COVID-19: A report from the national COVID scientific advisory panel, Wellcome Open Res., 5, 139, 10.12688/wellcomeopenres.15927.1 He, 2020, Temporal dynamics in viral shedding and transmissibility of COVID-19, Nature Med., 26, 672, 10.1038/s41591-020-0869-5 Wölfel, 2020, Virological assessment of hospitalized patients with COVID-2019, Nature, 581, 465, 10.1038/s41586-020-2196-x Long, 2020, Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections, Nature Med., 26, 1200, 10.1038/s41591-020-0965-6 Kambhampati, 2020, COVID-19–associated hospitalizations among health care personnel — COVID-NET, 13 states, March 1–May 31, 2020, MMWR. Morb. Mortal. Wkly. Rep., 69, 1576, 10.15585/mmwr.mm6943e3 Centers for Disease Control and Prevention, 2020 Prevent Epidemics, 2020 STRENDA Guidelines, https://doi.org/10.3762/strenda.17. Plant, 2014, Improved reproducibility by assuring confidence in measurements in biomedical research, Nature Methods, 11, 895, 10.1038/nmeth.3076 Centers for Disease Control and Prevention, 2020 Plant, 2018, How measurement science can improve confidence in research results, PLOS Biol., 16, 10.1371/journal.pbio.2004299